Radiotherapy Outcomes and Prognostic Factors in Head and Neck <scp>NUT</scp> Carcinoma: A Single‐Center Cohort Analysis
Prognosis in head and neck NUT carcinoma treated with radiotherapy is affected by disease status, primary site, radiotherapy dose, and adjuvant therapy. Locally advanced patients benefit most from high-dose radiotherapy and adjuvant therapy. GTV > 3.5 cm identifies high-risk populations requiring intensified treatment, while BETi may improve outcomes in postoperative recurrence/metastasis.
Authors
- Zhuomiao Ye (ORCID: https://orcid.org/0000-0003-2983-5944)
- Mingzhu Yin (ORCID: https://orcid.org/0000-0002-6964-7131)
- Helei Yan (ORCID: https://orcid.org/0000-0001-5552-503X)
- Fei Xie (ORCID: https://orcid.org/0000-0002-2437-1901)
- Xin Li (ORCID: https://orcid.org/0000-0001-8140-0484)
- Chao Deng (ORCID: https://orcid.org/0000-0002-1994-949X)
- Dan Yang
Institutions
- Chongqing University (CN)
- Chongqing Three Gorges Central Hospital (CN)
- Chongqing Cancer Hospital (CN)
- Chongqing Three Gorges University (CN)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1002/hed.70119
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00